GlassScriptPhysician profile
Melanie G Rushing
NPI 1770572703
$2,323.45
in general payments reported to CMS, 2019-2025
17 companies · $532 in 2025
The $532 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $99.32 · 2021: $301 · 2022: $189 · 2023: $455 · 2024: $335 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $371.51 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $363.53 | 2022-2025 | Infuse, Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $279.75 | 2025 | Xdemvy |
| Coopervision INC. | $242.54 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Glaukos Corporation | $188.73 | 2021-2022 | |
| Oyster Point Pharma, INC. | $188.00 | 2022-2023 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $166.99 | 2020-2024 | Acuvue |
| Ocular Therapeutix, INC. | $138.07 | 2024 | Dextenza |
| Alcon Vision LLC | $99.70 | 2021-2025 | Precision7, Precision 1, Total30 |
| Novartis Pharmaceuticals Corporation | $74.75 | 2019-2023 | |
| Abbvie INC. | $43.96 | 2022 | |
| Allergan, INC. | $32.39 | 2021-2022 | |
| Abb Con-Cise Optical Group LLC | $32.38 | 2023 | Spectacle Lenses, Contact Lens |
| Harrow Eye, LLC | $31.45 | 2025 | Vevye |
| Astellas Pharma US INC | $31.27 | 2024 | Izervay |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $19.49 | 2019 | |
| Maculogix, INC. | $18.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Rushing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.